|
Eli Lilly and Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1018
|
$944B |
14.8x |
32.7x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$249
|
$627B |
6.7x |
17.5x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$234
|
$476B |
7.8x |
18.2x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$121
|
$335B |
5.2x |
11.2x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$386
|
$253B |
7.0x |
14.3x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$150
|
$202B |
6.9x |
12.6x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$27
|
$201B |
3.2x |
8.1x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$62
|
$163B |
3.4x |
8.7x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$486
|
$119B |
9.9x |
22.0x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$791
|
$77.7B |
5.5x |
15.5x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$129
|
$61.4B |
6.5x |
14.9x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$325
|
$41.5B |
11.1x |
59.1x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$16
|
$31.6B |
2.2x |
7.7x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$146
|
$30.7B |
59.7x |
-27.4x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$188
|
$30.4B |
3.1x |
10.0x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$514
|
$19.0B |
5.9x |
11.4x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$17.9B |
4648.8x |
-15.8x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$16.5B |
3.5x |
18.5x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$53
|
$16.4B |
8.6x |
-5.1x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$100
|
$16.4B |
3.3x |
10.3x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$28
|
$15.7B |
854.2x |
-14.0x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$190
|
$14.7B |
3.5x |
15.6x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$14.0B |
28.3x |
-30.5x |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$13.0B |
N/A |
N/A |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$82
|
$12.5B |
14.0x |
-33.9x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$12.2B |
4.3x |
18.5x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$16
|
$11.9B |
N/A |
-11.6x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$11.0B |
99.2x |
N/A |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$60
|
$10.6B |
3.3x |
14.3x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$70
|
$10.2B |
7.6x |
11.7x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$107
|
$10.2B |
3.3x |
-8.3x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$9.9B |
1.6x |
5.2x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$9.8B |
4.2x |
10.4x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$436
|
$9.1B |
9.6x |
-31.0x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$337
|
$9.1B |
30365.3x |
-30.5x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$166
|
$8.4B |
13.4x |
-51.3x |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$64
|
$8.4B |
11.6x |
209.7x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$61
|
$7.7B |
96.2x |
-12.8x |
|
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$7.0B |
N/A |
-16.9x |
|
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$91
|
$6.9B |
129.1x |
-21.8x |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$14
|
$6.8B |
2.3x |
10.0x |
|
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$259
|
$6.8B |
17.4x |
40.2x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$178
|
$6.4B |
N/A |
N/A |
|
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$6.3B |
3.5x |
6.6x |
|
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$114
|
$6.2B |
189.6x |
-24.6x |
|
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$95
|
$6.1B |
32.3x |
-31.7x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$5.7B |
N/A |
-21.3x |
|
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$94
|
$5.5B |
84.6x |
-37.2x |
|
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$90
|
$5.3B |
10.5x |
-338.8x |
|
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$76
|
$5.3B |
3.5x |
9.8x |
|
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$28
|
$4.9B |
N/A |
-9.7x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$108
|
$4.9B |
N/A |
-29.4x |
|
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$12
|
$4.8B |
1.1x |
6.6x |
|
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$29
|
$4.8B |
7.9x |
34.6x |
|
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$14
|
$4.7B |
7.4x |
43.9x |
|
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$42
|
$4.3B |
N/A |
-38.1x |
|
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$4.3B |
N/A |
-15.1x |
|
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$69
|
$4.3B |
3.8x |
11.6x |
|
CG Oncology
|
United States of America |
Drug Development & Therapeutics
|
$59
|
$4.2B |
1542.2x |
-21.4x |
|
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$43
|
$4.2B |
N/A |
-10.5x |
|
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$61
|
$4.1B |
504.8x |
-7.3x |
|
Erasca
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$4.0B |
N/A |
-27.7x |
|
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$4.0B |
2.7x |
10.4x |
|
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$203
|
$3.8B |
14.2x |
35.2x |
|
Structure Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$63
|
$3.7B |
N/A |
-13.3x |
|
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$3.5B |
4.3x |
23.9x |
|
Alumis
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$3.4B |
135.3x |
-13.8x |
|
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$27
|
$3.2B |
9.0x |
-1681.7x |
|
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$46
|
$3.1B |
4.7x |
29.4x |
|
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$33
|
$3.1B |
N/A |
-9.4x |
|
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$33
|
$3.1B |
115.0x |
-14.9x |
|
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$3.1B |
638.0x |
-6.5x |
|
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$3.1B |
2.8x |
26.4x |
|
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$2.9B |
2.1x |
13.9x |
|
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$55
|
$2.9B |
4.1x |
22.6x |
|
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$76
|
$2.9B |
6.5x |
-45.4x |
|
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$2.8B |
374.7x |
-7.8x |
|
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$2.8B |
2.7x |
-19.4x |
|
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$42
|
$2.7B |
N/A |
-12.9x |
|
Liquidia
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$31
|
$2.7B |
18.5x |
-51.1x |
|
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$2.7B |
5.5x |
308.8x |
|
Edgewise Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$30
|
$2.7B |
N/A |
-14.5x |
|
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.7B |
2.6x |
39.5x |
|
Viridian Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$30
|
$2.6B |
30.2x |
-9.2x |
|
BioCryst Pharma
|
United States of America |
Drug Development & Therapeutics
|
$9
|
$2.6B |
4.2x |
27.3x |
|
Denali Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.5B |
928.3x |
-4.7x |
|
Vera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$2.5B |
N/A |
-8.3x |
|
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$4
|
$2.5B |
4.2x |
18.8x |
|
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$14
|
$2.4B |
56.9x |
-11.9x |
|
Adaptive Biotech
|
United States of America |
Pharma Diagnostics & Analytics,
Drug Development & Therapeutics
|
$16
|
$2.3B |
8.8x |
-1136.6x |
|
IDEAYA Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$33
|
$2.3B |
10.6x |
-14.7x |
|
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$24
|
$2.2B |
3.9x |
8.2x |
|
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$54
|
$2.2B |
8.0x |
30.9x |
|
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$23
|
$2.1B |
28.5x |
-16.2x |
|
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$2.1B |
275.3x |
-10.2x |
|
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$16
|
$2.1B |
1.0x |
-5.9x |
|
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$75
|
$2.0B |
2.3x |
9.0x |
|
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$55
|
$2.0B |
874.0x |
N/A |
|
Beam Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$29
|
$2.0B |
53.2x |
-4.2x |
|
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$67
|
$1.9B |
N/A |
-8.1x |